Human recombinant glutamate oxaloacetate transaminase 1 (GOT1) supplemented with oxaloacetate induces a protective effect after cerebral ischemia
Open Access
- 9 January 2014
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 5 (1) , e992
Abstract
Blood glutamate scavenging is a novel and attractive protecting strategy to reduce the excitotoxic effect of extracellular glutamate released during ischemic brain injury. Glutamate oxaloacetate transaminase 1 (GOT1) activation by means of oxaloacetate administration has been used to reduce the glutamate concentration in the blood. However, the protective effect of the administration of the recombinant GOT1 (rGOT1) enzyme has not been yet addressed in cerebral ischemia. The aim of this study was to analyze the protective effect of an effective dose of oxaloacetate and the human rGOT1 alone and in combination with a non-effective dose of oxaloacetate in an animal model of ischemic stroke. Sixty rats were subjected to a transient middle cerebral artery occlusion (MCAO). Infarct volumes were assessed by magnetic resonance imaging (MRI) before treatment administration, and 24 h and 7 days after MCAO. Brain glutamate levels were determined by in vivo MR spectroscopy (MRS) during artery occlusion (80 min) and reperfusion (180 min). GOT activity and serum glutamate concentration were analyzed during the occlusion and reperfusion period. Somatosensory test was performed at baseline and 7 days after MCAO. The three treatments tested induced a reduction in serum and brain glutamate levels, resulting in a reduction in infarct volume and sensorimotor deficit. Protective effect of rGOT1 supplemented with oxaloacetate at 7 days persists even when treatment was delayed until at least 2 h after onset of ischemia. In conclusion, our findings indicate that the combination of human rGOT1 with low doses of oxaloacetate seems to be a successful approach for stroke treatmentKeywords
This publication has 20 references indexed in Scilit:
- Blood Glutamate Scavenging: Insight into NeuroprotectionInternational Journal of Molecular Sciences, 2012
- Role of elevated liver transaminase levels in the diagnosis of liver injury after blunt abdominal traumaExperimental and Therapeutic Medicine, 2012
- Blood levels of glutamate oxaloacetate transaminase are more strongly associated with good outcome in acute ischaemic stroke than glutamate pyruvate transaminase levelsClinical Science, 2011
- High blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic strokeJournal of Cerebral Blood Flow & Metabolism, 2011
- Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: An experimental studyJournal of Cerebral Blood Flow & Metabolism, 2011
- Equipoise among recanalization strategiesNeurology, 2010
- The Neuroprotective Effects of Oxaloacetate in Closed Head Injury in Rats is Mediated by its Blood Glutamate Scavenging ActivityJournal of Neurosurgical Anesthesiology, 2009
- Methodological Quality of Animal Studies of Neuroprotective Agents Currently in Phase II/III Acute Ischemic Stroke TrialsStroke, 2009
- Neuroprotection for ischemic stroke: Past, present and futureNeuropharmacology, 2008
- Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug DevelopmentStroke, 1999